Esmolol is a cardioselective beta-1 adrenergic receptor antagonist used intravenously for acute tachycardia and hypertension. It is a valuable research tool for in vitro and in vivo studies of cardiac function and adrenergic signaling, with no significant association with drug-induced liver injury.
